Variant report
Variant | nsv965163 |
---|---|
Chromosome Location | chr3:46064891-46067930 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536993061 | chr3:46064906-46064907 | ZNF genes & repeats Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144489731 | chr3:46064913-46064914 | ZNF genes & repeats Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576258125 | chr3:46064997-46064998 | ZNF genes & repeats Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148437478 | chr3:46065034-46065035 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555856710 | chr3:46065050-46065051 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185879119 | chr3:46065065-46065066 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544684332 | chr3:46065077-46065078 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375898911 | chr3:46065087-46065088 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560057788 | chr3:46065104-46065105 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs36110050 | chr3:46065198-46065199 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568561238 | chr3:46065220-46065221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189659509 | chr3:46065278-46065279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs72887139 | chr3:46065302-46065303 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs531549448 | chr3:46065361-46065362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182887884 | chr3:46065386-46065387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571771626 | chr3:46065435-46065436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs371607473 | chr3:46065508-46065509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547564857 | chr3:46065534-46065535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566111497 | chr3:46065560-46065561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536231458 | chr3:46065612-46065613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536116287 | chr3:46065653-46065654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35174940 | chr3:46065707-46065708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs61415325 | chr3:46065721-46065722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569982490 | chr3:46065726-46065727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554057102 | chr3:46065741-46065742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35930050 | chr3:46065763-46065764 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs558681699 | chr3:46065838-46065839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577330187 | chr3:46065856-46065857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545131826 | chr3:46065858-46065859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553585979 | chr3:46065866-46065867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572039697 | chr3:46065868-46065869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368233070 | chr3:46065930-46065931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34584867 | chr3:46065963-46065964 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs143976358 | chr3:46066071-46066072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531587210 | chr3:46066194-46066195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557826985 | chr3:46066303-46066304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543650005 | chr3:46066433-46066434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188640706 | chr3:46066477-46066478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547408369 | chr3:46066480-46066481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532203822 | chr3:46066494-46066495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547896926 | chr3:46066561-46066562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561953000 | chr3:46066585-46066586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559577757 | chr3:46066592-46066593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530122273 | chr3:46066609-46066610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs143924649 | chr3:46066675-46066676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs72018671 | chr3:46066681-46066682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146414313 | chr3:46066734-46066735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537200074 | chr3:46066762-46066763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs61301137 | chr3:46066763-46066764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570020211 | chr3:46066808-46066809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Breast cancer | 21509527 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:46061600-46068400 | Weak transcription | GM12878-XiMat | blood |
2 | chr3:46061800-46065400 | Weak transcription | Osteobl | bone |
3 | chr3:46064600-46065000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr3:46064800-46065200 | Flanking Active TSS | K562 | blood |
5 | chr3:46065000-46065200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr3:46065200-46068600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr3:46065400-46066000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr3:46065400-46066000 | Enhancers | Osteobl | bone |